Natural selection for greener cleaning products?
LAVAL, QC, April 3, 2025 /CNW/ - Produced biologically using bacteria, these 'natural soaps' are a more environmentally friendly, less irritating and non-toxic alternative to synthetic surfactants derived from petrochemical processes, which are found in most soaps, detergents, shampoos, etc. However, the inadequate performance of the bacteria that produce them and the very high cost of production remain major development and marketing hurdles.
Natural selection to increase the production of secondary metabolites: a first
Professor Eric Déziel, an expert in microbiology and bacterial multicellularity, has long been interested in these biosurfactants and is a pioneer in this field. He wants to improve the production of these bacteria-based 'natural soaps' and make their use widespread. Together with his team, he recently developed a novel Adaptive Laboratory Evolution (ALE) procedure, a directed evolution method based on natural selection (darwinism), to improve the productivity of biosurfactants. It is the subject of the article 'Implementation of an adaptive laboratory evolution strategy for improved production of valuable microbial secondary metabolites' recently published in Bioresource Technology.
The laboratory, which is specialized in sociomicrobiology (social behaviour of bacteria), is the first to use such a strategy to increase the production of so-called 'secondary' metabolites, here biosurfactants, using bacteria. This is exceptional since ALE strategies, which are based on a 'fitness' advantage, are normally used to improve essential organism traits. However, the biosurfactants studied here are not crucial to bacteria survival.
'Using natural selection to increase the production of secondary metabolites, in this case biosurfactants, provides a unique perspective in the field of biotechnology. This will enable new bioprocesses to be developed to valorize wastes and replace chemicals. This is very promising for the bioeconomy since it is based on the performance of bacteria, not their growth, as in traditional methods.'
Professor Eric Déziel, INRS microbiologist
A promising new bacterium being studied
For this study, Professor Déziel's team, based at the INRS Armand-Frappier Santé Biotechnologie Research Centre, used a new biosurfactant-producing bacterium named Burkholderia thailandensis. The bacterium does not pose a risk to humans, contrary to Pseudomonas aeruginosa, which is generally used for the commercial production of rhamnolipids, one of the two main biosurfactants currently available on the market. The 'swarming' type of social motility expressed by B. thailandensis in order to effectively colonize its environment requires the production of rhamnolipids. These 'soaps' act as motility facilitators by wetting the surface and reducing surface tension and friction.
When growing bacteria in the laboratory, microbiologists use agar as a gelling agent for nutrient media. The research team hypothesized that an increase in agar levels during swarming experiments would force cells to produce more surfactants to move more easily over the surface. Consecutive cycles of B. thailandensis cultures on swarming media achieved with increasing concentrations of agar indeed increased the production of rhamnolipids, with the surfactants acting as a wetting agent, by evolved populations.
In addition, the study of these evolved bacterial populations has identified a previously unknown protein, QsmR, which acts as a suppressor of rhamnolipid production. This is an unexpected discovery that promises further advances in the production of biosurfactants by Burkholderia bacteria.
Paving the way to sustainable biotechnology
The natural selection experimental strategy developed by Professor Déziel's team could be used by researchers to improve the performance of new producing bacteria. This would increase the variety of 'natural soaps' available to meet different consumer needs and thus make this sustainable alternative to chemicals more widely available.
It could represent a revolution in the field, since surfactants, ingredients widely used in cleaning, personal care and pharmaceutical products, currently represent a market of more than $50 billion. The industry has already expressed its interest in this innovative methodology to Professor Déziel.
About the study
The article 'Implementation of an adaptive laboratory evolution strategy for improved production of valuable microbial secondary metabolites' by Sarah Martinez, David N. Bernard, Marie-Christine Groleau, Mylène C. Trottier and Eric Déziel, was published in Bioresource Technology on March 4, 2025.
'Participating in this innovative project was an enriching experience for my doctorate, driven by the curiosity to apply a simple but bold idea, knowing that it would have an impact on the future of research into biosurfactants. Working on the basis of the principles of natural selection allows us to free ourselves from GMO concepts, which can sometimes be poorly regarded in biotechnology, thus offering new study perspectives.'
PhD graduate Sarah Martinez, INRS
This research was funded by the Natural Sciences and Engineering Research Council of Canada, with the support of the Armand-Frappier Foundation.
About INRS
INRS is an academic institution dedicated exclusively to graduate research and training in strategic sectors in Quebec. For the past 55 years, it has actively contributed to Quebec's economic, social, and cultural development. INRS is first in Canada in research intensity. It is made up of four interdisciplinary research and training centres located in Quebec City, Montreal, Laval, and Varennes, which focus their efforts on strategic sectors: water, earth, and environment ( Eau Terre Environnement Research Centre); energy, materials, and telecommunications ( Énergie Matériaux Télécommunications Research Centre); urbanization, culture, and society ( Urbanisation Culture Société Research Centre); and health and biotechnology ( Armand-Frappier Santé Biotechnologie Research Centre). The INRS community includes over 1,500 students, postdoctoral fellows, and faculty and staff members.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
07-08-2025
- Yahoo
Genome BC Funds Research into the Respiratory Fallout of Wildfires
VANCOUVER, BC, Aug. 6, 2025 /CNW/ - British Columbians know the stark realities of climate change, as wildfires surge across the province. Over a million hectares burned across BC in 2024, blanketing communities in thick smoke and dramatically increasing the number of hazy, lung-choking days. As summer becomes a season of smoke, this escalating environmental challenge also has a hidden, insidious impact: a profound and lasting toll on our respiratory health. Wildfire smoke is more than just an inconvenience; it's a dangerous cocktail of particulate matter that infiltrates our lungs and bodies, exacerbating existing conditions and potentially triggering new ones. The costs are staggering, both in human lives and healthcare dollars, with Health Canada estimating up to 240 deaths and $1.8 billion in annual costs due to short-term health effects alone. In response to this challenge, Genome BC is funding three research projects that will delve into the genetic-level impacts of wildfire smoke exposure. "These projects are specifically designed to uncover what makes our vulnerable populations – from newborns to those with chronic lung conditions – more susceptible to wildfire-related respiratory issues," said Suzanne Gill, Genome BC's President and CEO. "We hope this knowledge can both inform treatment and care within our healthcare system and reduce the overall economic toll of wildfires." PROJECT 1: Wildfire Exposure and Early Childhood Health The next generation of British Columbians could be feeling the effects of wildfires before they even take their first breath. This project uses a holistic approach to study the impact of disaster exposure during pregnancy, including if it can have lasting effects on how genes are expressed in developing children. This may increase the risk of respiratory diagnoses such as asthma, bronchitis, wheezing, hives, eczema and other allergic reactions. Lead Researcher, Dr. Michael Kobor of the University of British Columbia believes the results can inform public health policies about respiratory health, especially vulnerable groups such as infants and pregnant people. "With this research, we aim to better our understanding of the impacts of prenatal wildfire disaster exposure on the next generation," he said. "Early-life environments can have a lasting impact on people throughout the course of their lives, including on their health outcomes. We hope this work will help shape healthy futures for children as global temperatures rise and wildfires become increasingly common." PROJECT 2: How Wildfire Smoke Affects People with Chronic Obstructive Pulmonary Disease (COPD) For the over 2 million Canadians living with Chronic Obstructive Pulmonary Disease (COPD), wildfire smoke presents a particularly grave threat. COPD is already the leading cause of hospitalization in Canada, costing our healthcare system an estimated $1.5 billion annually. Wildfire smoke can significantly worsen symptoms and lead to severe complications for COPD patients. Dr. Graeme Koelwyn from Simon Fraser University and and Dr. Don Sin from the University of British Columbia are studying the genomic changes in innate immune cells — our first line of defense against inhaled particles — of COPD patients. Their research aims to understand how these immune cells respond to wildfire smoke in patients at the genetic level as symptoms become worse, and to identify effective treatments. "This information is critical to develop disease management and exposure mitigation strategies for people living with COPD," Dr. Koelwyn said, "especially in this time of increasing societal and financial burden within our changing world and environment." PROJECT 3: How Wildfire Smoke and Aeroallergens Affect Lung Health Dr. Emilia Lim and Dr. Min Hyung Ryu from the University of British Columbia are focusing on airborne allergens (aeroallergens) triggered by the increase of atmospheric carbon dioxide and high temperatures that happen when there are frequent wildfires. These situations also tend to prolong allergy seasons. Our bodies generate an immune response to protect us when aeroallergens enter our lungs. "Aeroallergens are harmful to everyone, but people with lung conditions such as asthma, COPD and lung cancer survivors are at higher risk," because their immune systems are theoretically less robust, Dr. Lim explains. "It's important to know how these groups are affected differently." The researchers want to understand the links between our individual genetic differences and environmental triggers. Dr. Ryu noted, "identifying populations that are susceptible to these changes can help us find better ways to prevent and treat respiratory diseases." The Value of Proactive Research The escalating financial burden of wildfire recovery underscores the urgent need for proactive strategies. These three projects exemplify how genomics research is providing critical insights into the complex interplay between our environment and our health. "With our proximity to wildfires and access to interdisciplinary teams, Canadian researchers are uniquely equipped to tackle these questions first-hand," said Gill. "The fundamental knowledge gained will lay the groundwork for better policy decisions and more efficient treatments in the future. Any breakthroughs in respiratory health or disease prevention will translate into economic benefits for British Columbians and beyond." About Genome British Columbia: Genome BC is a not-for-profit organization that has advanced genomics research and innovation for 25 years, growing a world-class life sciences sector in BC and delivering sustainable benefits for British Columbia, Canada and beyond. Genome BC has attracted over $1.1 billion in direct co-investment to the province, which has contributed to funding more than 600 genomics research and innovation projects. These initiatives enhance healthcare and address environmental and natural resource challenges, improving the lives of British Columbians. Genome BC also integrates genomics into society by supporting responsible research and innovation and fostering an understanding and appreciation of the life sciences among educators, students and the public. SOURCE Genome British Columbia View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
01-08-2025
- Yahoo
MEDIA ADVISORY: Baycrest Experts Available During AAIC® 2025 in Toronto
TORONTO, July 25, 2025 /CNW/ - From July 27 to 31, Toronto hosts the Alzheimer's Association International Conference® 2025 (AAIC®), the world's largest forum for dementia research. With Canada in the spotlight, Baycrest is recognized globally for its leadership in aging and brain health. Our scientists and experts are participating in the conference and available to support your coverage. This international gathering offers a timely opportunity to explore the growing impact of dementia on families, economies and health care systems, along with the latest advances in prevention, care, treatment and research. Dr. Howard ChertkowScientific Director, Baycrest's Kimel Family Centre for Brain Health & WellnessScientific Director, Canadian Consortium on Neurodegeneration in Aging (CCNA)Dr. Chertkow is a member of the AAIC Scientific Program Committee and one of Canada's most respected dementia researchers. He is available to speak on topics including dementia detection, prevention, treatment and Canada's role in the global research landscape. More Baycrest Experts You Can Speak With Dr. Adriana Shnall, Program Director, Baycrest Koschitzky Centre for Innovations in Caregiving, can speak to innovative tools supporting dementia caregivers, including those in rural and underserved communities. At AAIC, she is co-presenting on the use of virtual reality, AI and other strategies to better support families in community and long-term care settings. Dr. Allison Sekuler, President & Chief Scientist, Baycrest Academy for Research and Education is available to speak on the rising prevalence of dementia in Canada and its impact on individuals, families and the healthcare system. Dr. Nicole Anderson, Associate Scientific Director, Baycrest's Kimel Family Centre for Brain Health & Wellness, can discuss the latest in dementia prevention research, including evidence that nearly half of all cases may be preventable. Baycrest combines world-class care with cutting-edge research to help shape the future of aging and brain health. If you are working on AAIC-related coverage or broader dementia stories, our experts are available for interviews throughout the conference. Throughout the week, we will share updates with media highlighting key topics, research developments and expert perspectives from Baycrest. Please contact Natasha Nacevski-Laird, Media Relations Specialist at Baycrest, to schedule an interview. About Baycrest At Baycrest, our vision is a world where every older person lives with purpose, fulfilment and dignity. Baycrest is a global leader in aging and brain health innovation, with over 105 years of expertise in seniors' care and cutting-edge research. Baycrest has been Designated with Exemplary Status by Accreditation Canada, and drives industry-leading care and safety outcomes. As the home of the Centre for Aging + Brain Health Innovation (CABHI) powered by Baycrest, the Baycrest Academy for Research and Education (BARE) and the Canadian Consortium on Neurodegeneration in Aging, Baycrest is at the forefront of dementia research. Affiliated with the University of Toronto, Baycrest's training programs shape the future of care globally, while Baycrest Global Solutions extends its expertise to senior living and healthcare internationally. For more information, visit: SOURCE Baycrest View original content to download multimedia:
Yahoo
28-07-2025
- Yahoo
MEDIA ADVISORY: Baycrest Experts Available During AAIC® 2025 in Toronto
TORONTO, July 25, 2025 /CNW/ - From July 27 to 31, Toronto hosts the Alzheimer's Association International Conference® 2025 (AAIC®), the world's largest forum for dementia research. With Canada in the spotlight, Baycrest is recognized globally for its leadership in aging and brain health. Our scientists and experts are participating in the conference and available to support your coverage. This international gathering offers a timely opportunity to explore the growing impact of dementia on families, economies and health care systems, along with the latest advances in prevention, care, treatment and research. Dr. Howard ChertkowScientific Director, Baycrest's Kimel Family Centre for Brain Health & WellnessScientific Director, Canadian Consortium on Neurodegeneration in Aging (CCNA)Dr. Chertkow is a member of the AAIC Scientific Program Committee and one of Canada's most respected dementia researchers. He is available to speak on topics including dementia detection, prevention, treatment and Canada's role in the global research landscape. More Baycrest Experts You Can Speak With Dr. Adriana Shnall, Program Director, Baycrest Koschitzky Centre for Innovations in Caregiving, can speak to innovative tools supporting dementia caregivers, including those in rural and underserved communities. At AAIC, she is co-presenting on the use of virtual reality, AI and other strategies to better support families in community and long-term care settings. Dr. Allison Sekuler, President & Chief Scientist, Baycrest Academy for Research and Education is available to speak on the rising prevalence of dementia in Canada and its impact on individuals, families and the healthcare system. Dr. Nicole Anderson, Associate Scientific Director, Baycrest's Kimel Family Centre for Brain Health & Wellness, can discuss the latest in dementia prevention research, including evidence that nearly half of all cases may be preventable. Baycrest combines world-class care with cutting-edge research to help shape the future of aging and brain health. If you are working on AAIC-related coverage or broader dementia stories, our experts are available for interviews throughout the conference. Throughout the week, we will share updates with media highlighting key topics, research developments and expert perspectives from Baycrest. Please contact Natasha Nacevski-Laird, Media Relations Specialist at Baycrest, to schedule an interview. About Baycrest At Baycrest, our vision is a world where every older person lives with purpose, fulfilment and dignity. Baycrest is a global leader in aging and brain health innovation, with over 105 years of expertise in seniors' care and cutting-edge research. Baycrest has been Designated with Exemplary Status by Accreditation Canada, and drives industry-leading care and safety outcomes. As the home of the Centre for Aging + Brain Health Innovation (CABHI) powered by Baycrest, the Baycrest Academy for Research and Education (BARE) and the Canadian Consortium on Neurodegeneration in Aging, Baycrest is at the forefront of dementia research. Affiliated with the University of Toronto, Baycrest's training programs shape the future of care globally, while Baycrest Global Solutions extends its expertise to senior living and healthcare internationally. For more information, visit: SOURCE Baycrest View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data